Previous close | 0.2500 |
Open | 0.1600 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 105.00 |
Expiry date | 2024-06-21 |
Day's range | 0.1600 - 0.2500 |
Contract range | N/A |
Volume | |
Open interest | 538 |
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.